top of page
Search
Admin
Jun 13, 20213 min read
Landos Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for Omilancor
https://www.globenewswire.com/news-release/2021/06/14/2246385/0/en/Landos-Biopharma-Announces-Positive-Outcome-of-End-of-Phase-2-Meeting-...
Admin
Jun 13, 20212 min read
Totient, a Helicase Venture Portfolio Company, has been Acquired by AbSci
Totient, a Helicase Venture portfolio company, has been acquired by AbSci, a synthetic biology company unlocking the potential of...
Admin
May 16, 20213 min read
Landos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets
BLACKSBURG, Va., and SHANGHAI, China and PRINCETON, N.J., May 17, 2021 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc (NASDAQ: LABP), a...
bottom of page